IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

SEC filing

IOVANCE BIOTHERAPEUTICS, INC.

IOVA · CIK 1425205

4 · Sep 3, 2026 · Director, Interim CEO & General Counsel Vogt Frederick G exercised options for 83.34K shares; reported 17.70K shares

Director, Interim CEO & General Counsel Vogt Frederick G exercised options for 83.34K shares; reported 17.70K shares

OWNERSHIP DOCUMENT

xslF345X06/tm2624648-3_4seq1.xmlSEC.gov

Graphics and non-inline formats (not embedded below).